Antares Pharma (AIS)
Antares Pharma Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 6.864M | 5.427M | 3.919M | 3.543M | 3.570M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | 1.991M | 2.144M | 1.807M | 1.393M | 1.453M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 4.874M | 3.283M | 2.112M | 2.150M | 2.117M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 2.877M | 1.574M | 1.429M | 1.946M | 1.749M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 2.094M | 1.871M | 1.949M | 1.800M | 1.779M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 6.962M | 5.589M | 5.186M | 5.139M | 4.981M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -0.0971M | -0.1624M | -1.266M | -1.596M | -1.412M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.0227M | 0.0084M | -0.0328M | 0.0423M | 0.0309M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -0.0744M | -0.1539M | -1.299M | -1.554M | -1.381M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -0.0744M | -0.1539M | -1.299M | -1.554M | -1.381M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -0.0744M | -0.1539M | -1.299M | -1.554M | -1.381M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -0.0744M | -0.1539M | -1.299M | -1.554M | -1.381M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 103.66 | 97.00 | 103.31 | 95.16 | 85.72 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 103.66 | 97.00 | 103.31 | 95.16 | 85.72 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | 0.00 | -0.01 | -0.02 | -0.02 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| EPS - Diluted net | 0.00 | -0.01 | -0.02 | -0.02 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
